Dear partners and friends,
We from Sciomics are hoping that you are all safe and well and would like to give you an update on our current activities in these challenging times.

To limit the spread of the COVID-19 virus and to ensure the safety of our employees as well as the continuation of all projects, Sciomics has early implemented preventive actions which have recently been further increased:
 
- only people critical to the laboratory activity are present on site
- implementation of non-overlapping teams for all on-site activities 
- efficient home office capabilities for all personnel

Through these actions, all our protein and post-translational analysis capabilities remain fully operational and we are able to continue all active projects as well as to begin new studies in the foreseeable future.  
Please feel free to contact us at any time if you have any questions or like to discuss how we may support you best during the current situation as well as in future projects.
 
As health is the highest good, we wish you all the best for you as well as your families and loved ones.

 

covid 19 operational v3 web

Our service portfolio

scioPhospho: protein profiling and phosphorylation status

scioPhospho: protein profiling and phosphorylation status

scioPhospho combines the advantages of a robust and cost-efficient protein expression profiling using scioDiscover with information on phosphorylation status. This combination provides a comprehensive overview on signalling events and pathway activity regulation. Features 1,300 highly relevant proteins are profiled in a single assay Phosphorylation status combined with protein expression levels…
Read more
scioUbi

scioUbi

Protein & ubiquitination profiling scioUbi is a high-content protein expression and ubiquitination level analysis. With scioUbi you can analyse up to 1,000 proteins in a single assay.   Features Screen…
scioDiscover - Protein Profiling on expression level

scioDiscover - Protein Profiling on expression level

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised…
scioCD - Cell surface marker and Cytokine profiling

scioCD - Cell surface marker and Cytokine profiling

  Characterise a certain cell type?   Cell composition in a certain tissue sample?   In-depth profiling of CD-marker expression?   Increase your throughput at high sensitivity levels? You aim…
scioCyto : Cytokine profiling

scioCyto : Cytokine profiling

scioCyto : Cytokine profiling scioCyto is a high-content analysis service for multiplex cytokine and chemokine profiling on protein level. A great variety of samples such as plasma, tissue, cells or…

News

Corona | Sciomics is fully operational

| 23 March 2020 | Through early preventive actions Sciomics is fully operational to address your protein profiling and biomarker projects. Thanks to our core laboratory team which is doing a fantastic job, while most of our employees are collaborating with you from home.

Stay heatlthy in these challenging times ! 
> more information

New article | Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer

| Jan 2019 | In the article, scientists at Tel Aviv University used our scioDiscover platform to analyse tumor-associated eosinophils in colorectal cancer. The full article is published in Cancer Immunology Research.

 

New article | Protection from ischemia reperfusion injury-induced inflammation and fibrosis in C5aR2-deficient mice

| June 2018 | Complement component 5a receptor 2 (C5AR2) deficient mice are protected from inflammation and fibrosis in response to ischemia reperfusion injury. Our scioPhospho platform supported scientists at the Medical School Hannover to elucidate the underlying mechanism. The data were recently published in Kidney International.

 

New article | Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells

| January 2018 | A scioDiscover protein microarray study contributed to an article in Cell Reports. In this study Gerard Ruiz-Babot et al. analysed a donor specific reprogramming of cells.

Customer testimonial Leonardo Guasti, PhD (senior author):

This has undoubtedly opened new avenues in our research. We have found the Sciomics team to be extremely helpful and efficient during the whole process, from advising the best strategy to the final interpretation of results.

> More testimonials

A glas full of hope | Ein Glas Hoffnung

| January 2018 | Article on the StartUp Sciomics and our antibody microarray platform by our partner SCHOTT nexterion.

> English version "A glass full of hope"

> Deutsche Version "Ein Glas Hoffnung"

Tweets

  • 7 days ago

    @MCDS_Therapy Welcome back and stay healthy !

  • 43 days ago

    RT @car_endo: #Antibodies are highly specific molecules, which recognizes a unique pattern, also called epitope, of a particular #protein.…

  • 47 days ago

    RT @car_endo: At Sciomics (@sciomics), the search for new protein #biomarkers is conducted using #antibody #microarray. Hundreds of differe…

  • 125 days ago

    RT @BioRNCluster: A new flavour to the traditional "Stammtisch". ☕️#BioRNEspresso: ‘Reacting to Covid-19 pandemic’: How emerging #biotechs

  • 126 days ago

    RT @car_endo: BioEndoCar has taken important measures to limit the spread of #COVID19 , including home-office and non-overlapping lab shift…